Stock Analiz

Orthopediatrics Corp. (KIDS) stock forecast and price target

Price $32.35 · data as of November 13, 2026

12-month price target

Average target$30.75
Upside / downside−4.9%
Analysts8
ConsensusNone
Low $27.00Average $30.75High $38.00

Gold marker: average target · white marker: today’s price ($32.35)

Analyst ratings

Strong buy 2Buy 4Hold 1Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-1.09−9.2%$272M
Next fiscal year
ends December 31, 2027
$-0.75+31.0%$304M
Next quarter
ends December 31, 2026
$-0.20+22.3%$69M
Quarter after
ends March 31, 2027
$-0.30+28.6%$67M

Consensus of the analysts covering Orthopediatrics, updated daily. In the last 30 days 2 estimates were raised and 2 lowered.

Our model vs. Wall Street

Analysts see 4.9% downside over 12 months. Our discounted cash flow model with moderate assumptions puts Orthopediatrics’s intrinsic value about 84% below today’s market value, and it scores 1.2 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.

Frequently asked questions

What is the Orthopediatrics stock price target?

The average 12-month target from 8 analysts is $30.75, 4.9% below the current price of $32.35 Targets range from $27.00 to $38.00.

Is Orthopediatrics a buy according to analysts?

The consensus rating is “None” (2 strong buy, 4 buy, 1 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is Orthopediatrics expected to earn?

Analysts expect EPS of $-1.09 for the fiscal year ending December 31, 2026 and $-0.75 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.